Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have Crohn's disease affecting the small bowel or colon, and your symptoms are currently under control (in remission)
- You are 16 years old or older
- You have had a special MRI scan of your bowel (called an MRE) either up to three months before, or within one month after, the decision to stop your biologic medication
- You are stopping your biologic medication specifically because your Crohn's disease is in remission — this includes medications such as Adalimumab, Infliximab, Certolizumab, Ustekinumab, Natalizumab, or Vedolizumab
Who may not be able to join:
- You are under 16 years of age
- You are only taking non-biologic medications for your Crohn's disease (unless you are also taking a biologic medication alongside them)
- You are stopping your biologic medication for a reason other than being in remission — for example, because the medication stopped working or caused side effects
- You had surgery to remove the affected part of your bowel after your MRI scan but before stopping your biologic medication
- You have not had an MRE scan within the required time window described above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maira Hameed, University College London Centre for Medical Imaging
Phone: 020 7679 9274
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To develop and internally evaluate a multivariable prediction model for early disease relapse in patients stopping biological therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.